iDEL Therapeutics
GermanyEntry
2025
Hold
1yr
Status
Active
Who owns iDEL Therapeutics?
iDEL Therapeutics is a German Biotech company, currently owned by NRW.BANK since 2025 and Gruenderfonds Ruhr.
Hand-verified · updated 2026-07-03
Open JSON · CC-BY
Most recent investor
Gruenderfonds RuhrGruenderfonds Ruhr II · 2024 · VC
2 ownership periods · full history below
Key facts
HQGermany
SectorBiotech
StatusActive
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2025 · present
NRW.BANKActive
2025 · present(1yr) · NRW.Venture · 2006 · VC
Gruenderfonds RuhrActive
2025 · present(1yr) · Gruenderfonds Ruhr II · 2024 · VC
More from Gruenderfonds Ruhr II
Other portfolio companies in the same fund.
More Gruenderfonds Ruhr portfolio companies
From the same investor, across funds.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns iDEL Therapeutics?
iDEL Therapeutics is currently owned by NRW.BANK and Gruenderfonds Ruhr, through Gruenderfonds Ruhr II, since 2025.
When did NRW.BANK and 1 other acquire iDEL Therapeutics?
NRW.BANK and 1 other acquired iDEL Therapeutics in 2025.
Who has owned iDEL Therapeutics over time?
iDEL Therapeutics has been through 2 private-equity ownership periods: NRW.BANK · via NRW.Venture · since 2025; Gruenderfonds Ruhr · via Gruenderfonds Ruhr II · since 2025.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue